# Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals Inc. (REGN) stock surges on positive social sentiment surrounding Dupixent sales and Michael Burry's investment, with BofA upgrading to 'Buy'. Concerns about stake reductions and data privacy are being overshadowed by strong trial results and analyst upgrades.

### About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious medical conditions.  
Regeneron Pharmaceuticals Inc uses the ticker $REGN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Regeneron Pharmaceuticals Inc (REGN) social dominance is up 161.6% from the previous month.
- Regeneron Pharmaceuticals Inc (REGN) Galaxy Score™ is up 73.81% from the previous [--] months.
- Regeneron Pharmaceuticals Inc (REGN) engagements is up 35.92% from the previous week.
- Regeneron Pharmaceuticals Inc (REGN) posts created is up 78.64% from the previous month.

### Price: $803.20
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/close.tsv)  
The stock price is up today, likely fueled by positive social sentiment around Dupixent sales growth and recent trial results, as well as Michael Burry's investment, offsetting concerns about stake reductions and data privacy issues. BofA's double upgrade to 'Buy' with a raised price target of $860 further bolsters this upward momentum.  

24-Hour: 1.78%
7-Day: 2.55%
30-Day: 9.57%

1-Year High: $812.30 on 2026-01-07  
1-Year Low: $483.10 on 2025-06-05  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/alt_rank.tsv)  
Regeneron Pharmaceuticals Inc (REGN) is currently AltRank #168 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +665  
[--] Month: [-----] +433  
[--] Months: [-----] +963  
[--] Year: [-----] +735  
1-Year High: [-----] on 2025-07-04  
1-Year Low: [--] on 2025-04-18  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +7  
[--] Month: [--] +22  
[--] Months: [--] +31  
[--] Year: [--] +23  
1-Year High: [--] on 2025-10-01  
1-Year Low: [--] on 2025-07-19  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +36%  
[--] Month: [-------] -7.20%  
[--] Months: [---------] -29%  
[--] Year: [----------] +18%  
1-Year High: [-------] on 2025-05-19  
1-Year Low: [-----] on 2026-01-19  

Engagements by network (24h):
YouTube: [--]
X: [------]
Reddit: [--]
News: [--]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -4.80%  
[--] Month: [-----] +44%  
[--] Months: [------] -15%  
[--] Year: [------] +49%  
1-Year High: [---] on 2025-06-27  
1-Year Low: [---] on 2025-12-07  

Mentions by network (24h):
YouTube: [--]
X: [---]
Reddit: [--]
News: [--]
TikTok: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Regeneron Pharmaceuticals Inc (REGN) in the last [--] hours which is down 8.80% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] -3.10%  
[--] Month: [-----] +68%  
[--] Months: [-----] -8.10%  
[--] Year: [-----] +141%  
1-Year High: [---] on 2025-06-27  
1-Year Low: [--] on 2026-01-03  

The most influential creators that mention Regeneron Pharmaceuticals Inc in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)             | [--]    | [------]    | [--]     | [------]      |
| [@nataninvesting](/creator/twitter/nataninvesting)   | [--]    | [------]    | [--]     | [-----]       |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]     | [--]     | [-----]       |
| [@Arturraposo1R](/creator/twitter/Arturraposo1R)     | [--]    | [-----]     | [--]     | [---]         |
| [@Tickeron](/creator/twitter/Tickeron)               | [--]    | [------]    | [--]    | [---]         |
| [@WJones_Global](/creator/twitter/WJones_Global)     | [--]    | [---]       | [--]     | [---]         |
| [@JandTContent](/creator/twitter/JandTContent)       | [--]    | [-----]     | [--]    | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@shabeezy84](/creator/twitter/shabeezy84)           | [--]    | [--]         | [--]     | [--]          |
| [@stocket_rocket](/creator/twitter/stocket_rocket)   | [--]   | [--]        | [--]     | [--]          |

[View More](/list/creators/regeneron-pharmaceuticals-inc/100)
  
  
### Sentiment: 85%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/sentiment.tsv)  
Current Value: 85%  
Daily Average: 73%  
[--] Week: 80% -5%  
[--] Month: 80% +14%  
[--] Months: 80% -1%  
[--] Year: 80% +1%  
1-Year High: 94% on 2025-07-06  
1-Year Low: 43% on 2025-12-07  

Most Supportive Themes:
- Dupixent Sales Growth: (50%) Social media is highlighting strong Dupixent sales growth, particularly with the launch for COPD, indicating strong potential for the company.
- Pipeline Optimism: (30%) Analysts and investors express optimism about Regeneron's pipeline and potential for future growth.
- Positive Technical Indicators: (13%) Several posts highlight positive technical indicators and potential for price increases.
  
Most Critical Themes:
- Stake Reduction and Data Privacy Concerns: (6%) Investors are expressing concerns about stake reduction and data privacy issues and the stock's underperformance.
  
  
  
### Social Dominance: 0.012%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/social_dominance.tsv)  
Current Value: 0.012%  
Daily Average: 0.051%  
[--] Week: 0.033% +0.015%  
[--] Month: 0.105% +0.065%  
[--] Months: 0.105% +0.047%  
[--] Year: 0.105% +0.032%  
1-Year High: 0.142% on 2025-03-12  
1-Year Low: 0.014% on 2026-02-13  
  
  
### Market Dominance: 0.096%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/market_dominance.tsv)  
Current Value: 0.096%  
Daily Average: 0%  
1-Year High: 0.147% on 2025-03-12  
1-Year Low: 0.072% on 2025-06-04  
  
  
### Market Cap: $84,910,976,585
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:regeneron-pharmaceuticals-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/regeneron-pharmaceuticals-inc/time-series/market_cap.tsv)  
Current Value: $84,910,976,585  
Daily Average: $67,236,712,816  
[--] Week: $84,318,575,652 +1.80%  
[--] Month: $84,910,976,585 +8.90%  
[--] Months: $84,910,976,585 +40%  
[--] Year: $84,910,976,585 +17%  
1-Year High: $85,369,141,623 on 2026-01-07  
1-Year Low: $52,154,892,636 on 2025-06-05  

### Top Regeneron Pharmaceuticals Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$OCUL WB see fair value of $29 Axpaxli in wet AMD NPDR and DME; and net cash. do not currently ascribe any value for Axpaxlis potential additional indications including retinal vein occlusion (RVO) or for other pipeline products. Our fair value assumes a 70% probability of success for Axpaxli in each indication with a commercial launch in late [----] in wet AMD and early [----] in NPDR and DME though we see potential for earlier launches given the companys recent announcement of plans to submit NDAs based on a single Phase III study. $OCUL What Can Axpaxli Achieve If It Establishes A 6-Month"  
[X Link](https://x.com/semodough/status/2022797696336023769) [@semodough](/creator/x/semodough) 2026-02-14T22:18Z 42.4K followers, [----] engagements


"$OCUL What Can Axpaxli Achieve If It Establishes A 6-Month Profile [--] month profile The current std of care anti-VEGF therapy is led by $REGN Eylea HD and Roche's Vabysmo and are delivered up to q16 week regimen although in the real-world its more like q10-12 week. $OCUL Pravin started commenting on SOL-1 masked rescue info in Jan'25. Following is a summary of most comments from Pravin related to SOL-1 mased rescue info since Jan'25. Also fed NotebookLM and had it create an infographic for fun. Takeaway: Pravin has been consistent. 1/2 https://t.co/uzHaE4SuGq $OCUL Pravin started commenting on"  
[X Link](https://x.com/semodough/status/2022791929344254400) [@semodough](/creator/x/semodough) 2026-02-14T21:55Z 42.4K followers, [----] engagements


"@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications"  
[X Link](https://x.com/PharmaAlerts/status/2022744046763151640) [@PharmaAlerts](/creator/x/PharmaAlerts) 2026-02-14T18:45Z [---] followers, [---] engagements


"Summary graphic of atopic dermatitis drugs/targets by benefit/treatment profile: SOC benchmarks: #Dupilumab $SNY $REGN and #Upadacitinib $ABBV Compare to: Injectables in Ph2b trials #APG777 $APGE #Rezpeg $NKTR Oral drugs in Ph2b trials #soquelitinib $CRVS KT-621 $KYMR @JoseRestonVA It's a smart bet I have a slightly different perspective on it: Dupi's [----] LOE will be unique in a way where they will still be a Best in Disease gold standard product. When dupi biosimilars come into the market they will be widely used bc of this gold standard efficacy and @JoseRestonVA It's a smart bet I have a"  
[X Link](https://x.com/HOThomasWPhelps/status/2022708426925556058) [@HOThomasWPhelps](/creator/x/HOThomasWPhelps) 2026-02-14T16:24Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing